Wednesday, January 27, 2021
Home Tags Hapbee

Tag: Hapbee

Satori Capital. Hapbee
Telehealth

Investment Manager With $1 Billion in Assets Under Management, Buys 300...

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
Hapbee
Telehealth

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Editor / Curator -
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

Editor / Curator -
Hapbee
All News

Hapbee’s (HAPB) Device, “Choose How You Feel.”

Editor / Curator -
Hapbee
Telehealth

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Editor / Curator -
Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Recent Headlines.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator -
12Page 1 of 2

Latest article

Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Uncategorized Editor / Curator -
Short Squeeze Mania Game Stop (GME) up 7,850%, in one year.National Beverage (FIZZ) up 86% in one week, 288%...

Video: Pacific Stem Cell

Stem Cells Editor / Curator -
With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...
ENDRA, Biotech Stock Review

Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.

Biotech News Editor / Curator -
Are Expectations of a 501K Approval Perking Up? We've learned through trial and error (with the better...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.